Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3872)
All Articles published online
|
Aug 14, 2009 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yang G, Huang C, Cao J, Huang KJ, Jiang T, Qiu ZJ. Lentivirus-mediated shRNA interference targeting STAT3 inhibits human pancreatic cancer cell invasion. World J Gastroenterol 2009; 15(30): 3757-3766 [PMID: 19673016 DOI: 10.3748/wjg.15.3757] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i30/3757.htm |
| Number | Citing Articles |
| 1 |
Chen Huang, Keping Xie. Crosstalk of Sp1 and Stat3 signaling in pancreatic cancer pathogenesis. Cytokine & Growth Factor Reviews 2012; 23(1-2): 25 doi: 10.1016/j.cytogfr.2012.01.003
|
| 2 |
Wan-Chi Tsai, Li-Yuan Bai, Yi-Jin Chen, Po-Chen Chu, Ya-Wen Hsu, Aaron M. Sargeant, Jing-Ru Weng. OSU-A9 inhibits pancreatic cancer cell lines by modulating p38-JAK-STAT3 signaling. Oncotarget 2017; 8(17): 29233 doi: 10.18632/oncotarget.16450
|
| 3 |
Han Hsi Wong, Nicholas R Lemoine. Novel therapies for pancreatic cancer: setbacks and progress. Future Oncology 2010; 6(7): 1061 doi: 10.2217/fon.10.70
|
| 4 |
XIUMEI LI, ZHUANG YU, YONG LI, SHIHAI LIU, CAIHONG GAO, XIN HOU, RUYONG YAO, LIANHUA CUI. The tumor suppressor miR-124 inhibits cell proliferation by targeting STAT3 and functions as a prognostic marker for postoperative NSCLC patients. International Journal of Oncology 2015; 46(2): 798 doi: 10.3892/ijo.2014.2786
|
| 5 |
Hua Zhu, Zhihong Jian, Yi Zhong, Yingze Ye, Yonggang Zhang, Xinyao Hu, Bei Pu, Lijuan Gu, Xiaoxing Xiong. Janus Kinase Inhibition Ameliorates Ischemic Stroke Injury and Neuroinflammation Through Reducing NLRP3 Inflammasome Activation via JAK2/STAT3 Pathway Inhibition. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.714943
|
| 6 |
Wen Peng, Weile Fang, Xiaona Gao, Xiaoquan Guo, Guyue Li, Fengping Guo, Guoliang Hu, Yu Zhuang, Lin Li, Chenxi Jiang, Ping Liu. Effect of RNA interference with HIF-1α on the growth of pulmonary artery endothelial cells in broiler chickens. Poultry Science 2024; 103(5): 103388 doi: 10.1016/j.psj.2023.103388
|
| 7 |
Zhenjie Yin, Yan Zhang, Yu Li, Tingting Lv, Jie Liu, Xinbo Wang. Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells. Acta Histochemica 2012; 114(2): 151 doi: 10.1016/j.acthis.2011.04.002
|
| 8 |
Jin-Dao Wang, Ketao Jin, Xiao-Ying Chen, Jie-Qing Lv, Ke-Wei Ji. Clinicopathological significance of SMAD4 loss in pancreatic ductal adenocarcinomas: a systematic review and meta-analysis. Oncotarget 2017; 8(10): 16704 doi: 10.18632/oncotarget.14335
|
| 9 |
Y.H. Xu, S. Lu. A meta-analysis of STAT3 and phospho-STAT3 expression and survival of patients with non-small-cell lung cancer. European Journal of Surgical Oncology (EJSO) 2014; 40(3): 311 doi: 10.1016/j.ejso.2013.11.012
|
| 10 |
Chin-Yap Loh, Aditya Arya, Ahmed Fadhil Naema, Won Fen Wong, Gautam Sethi, Chung Yeng Looi. Signal Transducer and Activator of Transcription (STATs) Proteins in Cancer and Inflammation: Functions and Therapeutic Implication. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00048
|
| 11 |
Malabika Sen, Jennifer R. Grandis. Nucleic acid-based approaches to STAT inhibition. JAK-STAT 2012; 1(4): 285 doi: 10.4161/jkst.22312
|
| 12 |
Hua Bai, Qi-Fang Zhang, Juan-Juan Duan, De-Jun Yu, Li-Jie Liu. Downregulation of signal transduction and STAT3 expression exacerbates oxidative stress mediated by NLRP3 inflammasome. Neural Regeneration Research 2018; 13(12): 2147 doi: 10.4103/1673-5374.241470
|
| 13 |
Sara Molenda, Agata Sikorska, Anna Florczak, Patryk Lorenc, Hanna Dams-Kozlowska. Oligonucleotide-Based Therapeutics for STAT3 Targeting in Cancer—Drug Carriers Matter. Cancers 2023; 15(23): 5647 doi: 10.3390/cancers15235647
|
| 14 |
Gang Zhao, Jun-gang Zhang, Ying Shi, Qi Qin, Yang Liu, Bo Wang, Kui Tian, Shi-chang Deng, Xiang Li, Shuai Zhu, Qiong Gong, Yi Niu, Chun-you Wang, Johannes Haybaeck. MiR-130b Is a Prognostic Marker and Inhibits Cell Proliferation and Invasion in Pancreatic Cancer through Targeting STAT3. PLoS ONE 2013; 8(9): e73803 doi: 10.1371/journal.pone.0073803
|
| 15 |
Qinghua Zhao, Chuan Wang, Jiaxue Zhu, Lei Wang, Shuanghai Dong, Guoqiao Zhang, Jiwei Tian. RNAi-mediated knockdown of cyclooxygenase2 inhibits the growth, invasion and migration of SaOS2 human osteosarcoma cells: a case control study. Journal of Experimental & Clinical Cancer Research 2011; 30(1) doi: 10.1186/1756-9966-30-26
|
| 16 |
Bo Li, Chen Huang. Regulation of EMT by STAT3 in gastrointestinal cancer (Review). International Journal of Oncology 2017; 50(3): 753 doi: 10.3892/ijo.2017.3846
|
| 17 |
P U Emeagi, S Maenhout, N Dang, C Heirman, K Thielemans, K Breckpot. Downregulation of Stat3 in melanoma: reprogramming the immune microenvironment as an anticancer therapeutic strategy. Gene Therapy 2013; 20(11): 1085 doi: 10.1038/gt.2013.35
|
| 18 |
YAO CUI, YUN-YUN LI, JIAN LI, HONG-YAN ZHANG, FENG WANG, XUE BAI, SHAN-SHAN LI. STAT3 regulates hypoxia-induced epithelial mesenchymal transition in oesophageal squamous cell cancer. Oncology Reports 2016; 36(1): 108 doi: 10.3892/or.2016.4822
|
| 19 |
Zhen-Jie Yin, Fa-Guang Jin, Tong-Gang Liu, En-Qing Fu, Yong-Hong Xie, Rui-Lin Sun. Overexpression of STAT3 Potentiates Growth, Survival, and Radioresistance of Non-Small-Cell Lung Cancer (NSCLC) cells. Journal of Surgical Research 2011; 171(2): 675 doi: 10.1016/j.jss.2010.03.053
|
| 20 |
Rawiah A. Alsiary, Talat Abdullah Albukhari, Waheed A. Filimban. Molecular Targets and Cancer Therapeutics (Part 1). 2023; : 273 doi: 10.2174/9789815080384123010010
|
| 21 |
Xiang Xia, Weidong Wu, Chen Huang, Gang Cen, Tao Jiang, Jun Cao, Kejian Huang, Zhengjun Qiu. SMAD4 and its role in pancreatic cancer. Tumor Biology 2015; 36(1): 111 doi: 10.1007/s13277-014-2883-z
|